Arthritis Research Center Foundation Inc

Pso registry bms: improving the public health by engaging in research to develop a more comprehensive understanding of the treatment landscape and outcomes of patients with psoriasis. Arcf will collaborate and/or partner with academic sites, investigators, and pharmaceutical companies (collectively, including arcf, "consortium or, individually, each a "consortium member") to further advance forward pso. Company wishes to support forward pso as a consortium industry partner.

Janssen ra: to characterize baseline demographic differences between individuals with ra vs individuals with iim and compare changes in patient report outcomes (pros) over time between individuals with ra and iim.

All other program service initiatives, including registry that uses the internet to create a community of arthritis patients, who willingly provide patient information to be used for discovery research and the development of personalized medicine for people with arthritis, to gather data to be used for analyses of heart disease in rheumatoid arthritis and using the ndb ra patient date from 1998 through june 2011 to determine the most common treatment pathways over the past decade and characterize the patients on these pathways.